PlainRecalls
FDA Drug Moderate Class II Terminated

Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-450-05.

Reported: March 13, 2019 Initiated: February 22, 2019 #D-1066-2019

Product Description

Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-450-05.

Reason for Recall

Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing.

Details

Recalling Firm
Ascend Laboratories LLC
Units Affected
3,072 bottles
Distribution
Nationwide in the USA and Puerto Rico.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-450-05.. Recalled by Ascend Laboratories LLC. Units affected: 3,072 bottles.
Why was this product recalled?
Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 13, 2019. Severity: Moderate. Recall number: D-1066-2019.